AHRQ

Prime Healthcare Hospitals Rank Among Best in the Nation for Patient Safety in 2024

Retrieved on: 
Monday, March 25, 2024
Nursing, Health, Hospitals, Surgery, Practice Management, General Health, Statistics, La Palma Intercommunity Hospital, Culture, Organization, Caregiver, Paradise Valley Hospital, Patient, Hospital, Health care, Mortality, MD, Centinela Hospital Medical Center, Quality, Heart, Safety, Patient safety, Injury, Medicare, St. Joseph's Hospital, AHRQ, Sherman Oaks Hospital

Prime Healthcare hospitals were well-represented as Healthgrades unveiled its 2024 Patient Safety Excellence Award™ recipients.

Key Points: 
  • Prime Healthcare hospitals were well-represented as Healthgrades unveiled its 2024 Patient Safety Excellence Award™ recipients.
  • In total, 21 Prime Healthcare and Prime Healthcare Foundation hospitals received Patient Safety Excellence Awards™ this year.
  • "We're proud to recognize these Prime Healthcare hospitals for providing top-quality care while preventing serious injuries to patients during their hospital stay."
  • The Prime Healthcare member hospitals that were recognized with Patient Safety Excellence Awards™ showcased high composite patient safety scores across a number of measures, including:
    In addition to the Patient Safety Excellence Award™ acclaims, Prime Healthcare hospitals also earned "America's 50 Best" and "America's 100 Best" distinctions from Healthgrades across a number of surgical and specialty categories in 2024.

Healthgrades Announces 2024 Top Hospitals in Patient Experience and Patient Safety

Retrieved on: 
Tuesday, March 12, 2024
Hospital, Statistics, Friends, Health, PSI, Patient, Health care, MD, Fracture, Safety, Patient safety, PSIS, Injury, Medicare, Family, CMS, AHRQ, Nursing

DENVER, March 12, 2024 /PRNewswire/ -- Healthgrades, the #1 site Americans use when searching for a doctor or hospital, today announced the recipients of two hospital quality awards. The 2024 Patient Safety Excellence Award™ recognizes hospitals nationwide that provide quality care while preventing serious safety events during hospital stays, and the 2024 Outstanding Patient Experience Award™ celebrates hospitals delivering best-in-class patient experiences. Only 79 hospitals received both Patient Safety and Outstanding Experience awards.

Key Points: 
  • The 2024 Patient Safety Excellence Award™ recognizes hospitals nationwide that provide quality care while preventing serious safety events during hospital stays, and the 2024 Outstanding Patient Experience Award™ celebrates hospitals delivering best-in-class patient experiences.
  • The Healthgrades Patient Safety Excellence Award recognizes 444 hospitals (the top 10% of evaluated hospitals) that excel in providing top-quality patient care while preventing serious injuries during hospital stays.
  • Hospitals could have avoided over 97,000 patient safety events between 2020 and 2022 if they all performed similarly to the 2024 Patient Safety Excellence Award winners.
  • View the full Patient Safety Excellence Award and Outstanding Patient Experience Award recipient lists on healthgrades.com .

Glytec Announces Major Expansion of Executive Team to Drive Innovation and Growth

Retrieved on: 
Tuesday, January 30, 2024
AHRQ, Growth, CFO, Agency, History, Patient, MSN, Glucommander, Hyperglycemia, SVP, Business operations, Health, Software as a service, Humana, Doctor of Philosophy, RN, Hypoglycemia, Hospital, Pharmaceutical industry

WALTHAM, Mass., Jan. 30, 2024 /PRNewswire/ -- Glytec, the only provider of cloud-based insulin management software as a service (SaaS) solutions across the continuum of care, proudly announces the addition of key healthcare leaders to its executive team to continue to scale the company, grow its client base, and meet the needs of the growing healthcare industry and diabetes technology market. 

Key Points: 
  • I feel privileged to collaborate with this team of experts with an extensive track record of healthcare innovation, positive patient impact at scale, and a history of remarkable success," said Patrick Cua, CEO of Glytec.
  • [2]
    The market demand for Glucommander is surging, and these seasoned executives will bring invaluable experience and skills to drive and support continued growth.
  • McPherson's strategic financial leadership will play a crucial role in sustaining Glytec's growth trajectory and fortifying the foundation for continued innovation.
  • These healthcare leaders will join a broader, dynamic team that is set to drive groundbreaking advancements in diabetes technology, healthcare applications, and market impact.

A UNIVERSAL CORONAVIRUS VACCINE COULD SAVE BILLIONS OF DOLLARS IF READY BEFORE NEXT PANDEMIC

Retrieved on: 
Thursday, January 11, 2024
Death, Computation, National Science Foundation, Operations research, Infection, Research, City University, Tropical medicine, Manuscript, Agency, Health, BCM, Baylor College of Medicine, Absenteeism, Baylor University, PRI, CUNY, MERS, MBA, City, AHRQ, Public health, State, Graduate Center, CUNY, COVID-19, Health policy, Public health informatics, Doctor of Philosophy, Human services, Lancet, Messenger, Bangladesh Technical Education Board, SARS, SARS-CoV-2, Coronavirus, National school, Model

NEW YORK, Jan. 11, 2024 /PRNewswire/ -- What if scientists had developed a universal coronavirus vaccine in the years prior to 2020 so that it was available at the start of the COVID-19 pandemic? A universal coronavirus vaccine targets parts of the virus that are common to either many or all coronaviruses, thereby offering some degree of protection against a range of strains. A new study suggests if such a vaccine were available at the start of the pandemic, it could have saved millions of lives, prevented suffering, and saved billions of dollars in direct medical and other costs until the strain-specific (i.e., SARS-CoV-2) vaccine went through the entire development, testing, and emergency use authorization process that lasted 10 months.

Key Points: 
  • NEW YORK, Jan. 11, 2024 /PRNewswire/ -- What if scientists had developed a universal coronavirus vaccine in the years prior to 2020 so that it was available at the start of the COVID-19 pandemic?
  • A universal coronavirus vaccine targets parts of the virus that are common to either many or all coronaviruses, thereby offering some degree of protection against a range of strains.
  • The experiments simulated what would happen if a universal coronavirus vaccine was available at the start of the COVID-19 pandemic.
  • A universal coronavirus vaccine was also shown to be highly cost-effective even if a more specific and more efficacious vaccine came to market.

Glytec Announces Patrick F. Cua as Chief Executive Officer

Retrieved on: 
Thursday, January 4, 2024
Brain damage, EHR, Agency, Risk, CUA, Acquisition, Software as a service, AHRQ, Glucommander, Hospital, Hyperglycemia, Medicare, Infection, Growth, Patient, Organization, Seizure, Hypoglycemia, CMS

WALTHAM, Mass., Jan. 4, 2024 /PRNewswire/ -- Glytec, the only provider of cloud-based insulin management software as a service (SaaS) solutions across the continuum of care, today announced the appointment of Patrick F. Cua as Chief Executive Officer. In his new role, Cua will prepare the company for rapid growth to meet increasing demand for Glucommander amid a surging industry focus on healthcare outcomes, cost savings, diabetes technology, and glycemic management.

Key Points: 
  • WALTHAM, Mass., Jan. 4, 2024 /PRNewswire/ -- Glytec , the only provider of cloud-based insulin management software as a service (SaaS) solutions across the continuum of care, today announced the appointment of Patrick F. Cua as Chief Executive Officer.
  • "Glytec is an early innovator for inpatient glycemic management SaaS and has built and maintained a reputation as the trusted partner for healthcare providers," said Cua.
  • I'm excited to grow the organization and scale its technology through this transformative time, not just for Glytec, but also for healthcare and the diabetes technology industry."
  • To learn more about Glytec and its insulin management software, visit https://glytecsystems.com/ .

AMN Healthcare Study Tracks 45 Languages Spoken in Patient/Provider Encounters in U.S.

Retrieved on: 
Tuesday, November 14, 2023
American Sign Language, Mandarin, Violence, Acquisition, ASL, Civil Rights Act, AHRQ, Language, Risk, Congo, Vietnamese, Patient, Agency, AMN, Amharic, United States Census Bureau, LEP, Hospital, Deafness, Democratic republic, Health care, Film industry, Health insurance

The new report is based on more than 204 million minutes – or more than 142,000 days -- of language interpretation services the company provided via AMN Healthcare Language Services for patients in hospitals, medical groups, and other clinical settings. That’s compared to 102 million minutes when AMN Healthcare compiled its inaugural report in 2021, a 100 percent increase in interpretation services provided.

Key Points: 
  • That’s compared to 102 million minutes when AMN Healthcare compiled its inaugural report in 2021, a 100 percent increase in interpretation services provided.
  • “Language diversity in healthcare is exploding,” said Jacobia Solomon, President of AMN Healthcare Language Services.
  • Spanish is the most commonly spoken language other than English in patient/provider encounters in 48 states, according to the report.
  • “Languages used in patient/provider healthcare encounters generally are regionalized based on migration patterns to the U.S.” Solomon said.

Community Health Systems’ Decade Long Commitment to Patient Safety Featured in NEJM Catalyst

Retrieved on: 
Wednesday, November 15, 2023
Other Health, Hospitals, Health, Nursing, Managed Care, Patient safety, CHS, Safety, NYSE, Patient safety organization, Community Health Systems, AHRQ, Risk, Patient, Data analysis, Caregiver, CYH, Hospital, Approximation error, PSO, Face, Fungal infection, Medical device, Medicine

Since then, the hospitals have achieved and maintained an 89% reduction in their Serious Safety Event Rate.

Key Points: 
  • Since then, the hospitals have achieved and maintained an 89% reduction in their Serious Safety Event Rate.
  • Through the PSO, CHS established a safety base-line in 2012 and began its journey to zero preventable harm.
  • “The catalyst in our journey to zero preventable harm was in analyzing baseline data for serious safety events and recognizing that preventable patient harm was occurring, similar to other health systems and consistent with reported trends,” says Lynn Simon, M.D., President, Healthcare Innovation and Chief Medical Officer of Community Health Systems.
  • “Across CHS, safety is a core value embedded in the hearts and minds of our caregivers – a commitment that is constant, unchanging, and unyielding in the face of the latest trends or competing priorities.”

Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System

Retrieved on: 
Wednesday, November 15, 2023
SHIELD, Sale, Robert Trivers, Food, AHRQ, Risk, CLIA, Database, Sepsis, Patient, Medicine, Agency, Viral, FDA, Infection, Acute decompensated heart failure, RNA, Diagnosis, Genetically modified bacteria, Messenger, HCUP, Immunotherapy, Vaccine, Pharmaceutical industry, Myrna

SUNNYVALE, Calif., Nov. 15, 2023 /PRNewswire/ -- Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the company has completed technical development for its TriVerity™ Acute Infection and Sepsis Test System, which includes the Myrna™ Instrument, and for the TriVerity™ Cartridge. TriVerity is intended to be used in emergency department settings in patients with suspected acute infection and sepsis to assess the likelihood of a bacterial infection, a viral infection, and risk of acute decompensation (the need for ICU-level care).    

Key Points: 
  • SUNNYVALE, Calif., Nov. 15, 2023 /PRNewswire/ -- Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the company has completed technical development for its TriVerity™ Acute Infection and Sepsis Test System, which includes the Myrna™ Instrument, and for the TriVerity™ Cartridge.
  • TriVerity is intended to be used in emergency department settings in patients with suspected acute infection and sepsis to assess the likelihood of a bacterial infection, a viral infection, and risk of acute decompensation (the need for ICU-level care).
  • The TriVerity Acute Infection and Sepsis Test, Inflammatix's lead product, incorporates a panel of 29 mRNAs to "read" the body's immune response and thus aid in the diagnosis of patients with suspected acute infection and sepsis.
  • The TriVerity Acute Infection and Sepsis Test System is a product in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction.

FAIR Health Wins Seven eHealthcare Leadership Awards for Its Consumer and Other Online Resources for 2023

Retrieved on: 
Thursday, November 9, 2023
Lyme disease, Kiplinger, Gold, White House, Personal finance, AHRQ, Health, Internet, News, Arizent, COVID-19, Body part, White, Platinum, Infection, Public, URAC, Social media, Nursing, Health insurance

NEW YORK, Nov. 9, 2023 /PRNewswire/ -- FAIR Health has won seven eHealthcare Leadership Awards for 2023, its 12th consecutive year of winning awards in this competition.

Key Points: 
  • NEW YORK, Nov. 9, 2023 /PRNewswire/ -- FAIR Health has won seven eHealthcare Leadership Awards for 2023, its 12th consecutive year of winning awards in this competition.
  • For the sixth year in a row, FAIR Health received the Mark Gothberg eHealthcare Organizational Commitment Award, the highest honor of the eHealthcare Leadership Awards.
  • The award recognizes industry leadership, innovation and commitment, according to the presenter of the awards, Plain-English Health Care.
  • Both consumer sites won an award for Best Mobile Website—FAIR Health Consumer a platinum award and FAIR Health Consumidor a gold award.

CORRECTION: Lundquist Investigator Dr. Loren Miller Is the Lead Author of the “Universal Decolonization” Study Published in the New England Journal of Medicine

Retrieved on: 
Wednesday, October 11, 2023
Chlorhexidine, Infection, Methicillin-resistant Staphylococcus aureus, Nursing, Doctor of Philosophy, The New England Journal of Medicine, Prevalence, Epidemiology, UCI, Hospital, MPH, University of California, Irvine, University, CDC, Agency for Healthcare Research and Quality, University of California, Irvine School of Medicine, Health, Harbor–UCLA Medical Center, AHRQ, MHSA, Nursing home, Fungal infection, Long-term care, MRSA, Povidone-iodine, Houston, Clinical trial, Nose, Institute of Health and Biomedical Innovation, Korea Disease Control and Prevention Agency, Skin, UCI School of Biological Sciences, Urinary tract infection, Enterococcus-1 RNA motif, Bed, Research, NIH, Pharmaceutical industry, MD, Medicine

The findings were published on October 10, 2023, in the New England Journal of Medicine.

Key Points: 
  • The findings were published on October 10, 2023, in the New England Journal of Medicine.
  • “The cleansing protocol, called universal decolonization, substantially reduced the number of nursing home residents requiring hospitalization due to infection,” said lead author and Lundquist Investigator, Loren Miller, MD, MPH.
  • Dr. Miller is the Chief of Infectious Diseases at the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Torrance, California.
  • “Nursing Home Decolonization for Infection and Hospitalization Prevention” published in the New England Journal of Medicine on October 10, 2023: https://www.nejm.org/doi/full/10.1056/NEJMoa2215254?query=featured_home